Immunovant, Inc. Units
IMVTU
IMVTU was delisted on the 5th of June, 2020.
6 hedge funds and large institutions have $31.2M invested in Immunovant, Inc. Units in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
14% less funds holding
Funds holding: 7 → 6 (-1)
48% less capital invested
Capital invested by funds: $60M → $31.2M (-$28.7M)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
+$190K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$16.9M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$106K |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$31.3K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$5.93K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CAM
1
Cormorant Asset Management
Boston,
Massachusetts
| $19.4M | -$31.3K | -1,620 | -0.2% |
|
|
PA
2
Perceptive Advisors
New York
| $7.36M | – | – | – |
|
|
PVI
3
Pura Vida Investments
New York
| $2.9M | +$190K | +9,840 | +6% |
|
|
SFM
4
Sphera Funds Management
Tel Aviv,
Israel
| $1.56M | -$106K | -5,500 | -6% |
|
|
5
UBS Group
Zurich,
Switzerland
| $13K | -$5.93K | -307 | -28% |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $3K | – | – | – |
|
|
EAM
7
Eventide Asset Management
Boston,
Massachusetts
| – | -$16.9M | -680,000 | Closed |
|
IMVTU Hedge Fund Activity: Q1 2020 in Review
6 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Immunovant, Inc. Units (IMVTU) for Q1 2020, worth a combined $31.2M — down 48% from $60M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of IMVTU and 0 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 1 added.
The largest buyer was Pura Vida Investments, adding an estimated $190K. The largest seller was Eventide Asset Management, exiting entirely with an estimated $16.9M sold.
- 6 institutional investors held Immunovant, Inc. Units (IMVTU) as of Q1 2020, down from 7 in Q4 2019.
- Funds reported $31.2M of Immunovant, Inc. Units stock for Q1 2020, down 48% quarter-over-quarter.
- 0 funds opened new Immunovant, Inc. Units positions in Q1 2020 and 1 closed out, a net change of -1 holder.
- The largest Immunovant, Inc. Units buyer in Q1 2020 was Pura Vida Investments, an estimated $190K added.
- The largest Immunovant, Inc. Units seller in Q1 2020 was Eventide Asset Management, an estimated $16.9M sold.
Based on aggregated 13F filings for Q1 2020.